Although the presence or absence of the mutant p53 allele did not affect the frequency of lung adenocarcinomas in KrasLA1 mice (62.5% versus 70.8%, respectively), metastases were much more frequent in those with p53 mutations than in those without (36.5% versus 4.5%). The gene discussed is TP53; the disease is lung adenocarcinoma.